Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors (Q37370587)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 May 2009

Language	Label	Description	Also known as
English	Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors	scientific article published on 12 May 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rajesh K Sharma

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Kutlu G Elpek

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Esma S Yolcu

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Rich-Henry Schabowsky

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Hong Zhao

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Laura Bandura-Morgan

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Haval Shirwan

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

12 May 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

69

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

4319-4326

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

CD137 costimulation of CD8 T cells confers resistance to suppression by virus-induced regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Toll or toll-free adjuvant path toward the optimal vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Cooperation of Toll-like receptor signals in innate immune defence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Cutting edge: CpG oligonucleotides induce splenic CD19 dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

RETRACTED: B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4 CD25 regulatory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Cancer vaccines: between the idea and the reality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Cutting edge: Expression of functional CD137 receptor by dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

The immunological synapse: a molecular machine controlling T cell activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

6 September 2017

CD4 CD25 T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

14 September 2017

Eradication of established tumors in mice by a combination antibody-based therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

14 September 2017

Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

14 September 2017

Turning on/off tumor-specific CTL response during progressive tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

14 September 2017

Cutting edge: Lipopolysaccharide induces IL-10-producing regulatory CD4 T cells that suppress the CD8 T cell response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

26 June 2018

Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

26 June 2018

In vivo stimulation of CD137 broadens primary antiviral CD8 T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

26 June 2018

Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8( ) T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2755220

2 September 2018

The 4-1BB costimulation augments the proliferation of CD4 CD25 regulatory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8 CTL to Cause Tumor Eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4 CD25 Treg cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4 T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expansion of CD4 CD25 FoxP3 T regulatory cells based on synergy between IL-2 and 4-1BB signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19435920

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/0008-5472.CAN-08-3141

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37370587&oldid=2115720226"